Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Sol-Gel Reports First Quarter 2025 Results
-
Sol-Gel Announces Reverse Share Split
-
Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.
-
Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
-
Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
-
Sol-Gel reports Second Quarter 2024 Financial Results and provides Corporate Updates
-
Sol-Gel reports Second Quarter 2024 Financial Results and provides Corporate Updates
-
Sol-Gel Announces the Signing of Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOLAY® in Europe and South Africa
-
Sol-Gel Technologies Announces Management Realignment
-
Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice